Dr. Felix J. Baker, Ph.D., is an American billionaire investor and scientist, the co-founder of Baker Bros. Advisors LP, one of the world's leading biotechnology-focused investment advisors. His career is defined by an unparalleled blend of elite scientific training and high-stakes finance. He holds a B.S. and a Ph.D. in Immunology from Stanford University, where he also completed two years of medical school.

Baker, along with his brother Julian Baker, recognized the immense, untapped financial potential of long-term investment in cutting-edge biotech research. Their investment philosophy is rooted in the belief that deep scientific knowledge can lead to superior investment returns, specializing in endowments and foundations as clients.

Dr. Felix Baker co-founded Baker Bros. Advisors LP in 2000. Their strategic vision was audacious: create a specialized hedge fund that would apply a scientist's rigor to the volatile biotech market. The firm quickly became a dominant force, taking large, long-term stakes in companies developing transformative therapeutics.

Under his management, Baker Bros. Advisors grew to manage billions of dollars, generating massive returns from successful bets on major biopharma firms like Alexion Pharmaceuticals and Seagen. Felix Baker is highly active in the governance of his portfolio, serving on the boards of multiple biotech companies, including Kodiak Sciences, IGM Biosciences, and Kymera Therapeutics. His wealth is secured by the immense appreciation of his concentrated biotech equity stakes, cementing his legacy as a titan of science-driven finance.

Felix Baker's social impact is structural, stemming from Baker Bros. Advisors' role in funding and accelerating the development of life-saving drugs and innovative therapeutics. His investment capital is crucial for advancing the field of biotechnology and medical science globally.

His personal philanthropy supports various scientific research and educational institutions, including Stanford University. His career is a powerful narrative of translating specialized scientific knowledge into immense financial power to fund the next generation of medical breakthroughs.

Dr. Felix Baker maintains the professional, intellectual style of a scientist-investor. His attire is consistently formal and high-quality, favoring tailored business suits. His aesthetic is one of stability and intellectual authority, reflecting his Ph.D. background and his financial success.

Residing in the U.S., his luxury is the immense security and financial reward derived from his multi-billion dollar fortune. His life is dedicated to leveraging scientific rigor for investment returns, focusing on transformative biotechnology and medical science.